BTN3A3 and neoplasm: Other immune-related genes of the nine-IRGP signature, including BTN3A3 [32], RORC [33], and AGER [34], participate in promoting tumorigenesis, decreasing efficacy of immunotherapy, and preventing tumor immune killing through a variety of immunological mechanisms.